Microbot Medical Inc MBOT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MBOT is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.90
- Day Range
- $0.86–0.95
- 52-Week Range
- $0.86–4.37
- Bid/Ask
- $0.88 / $0.88
- Market Cap
- $12.82 Mil
- Volume/Avg
- 211,777 / 98,611
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 22
- Website
- https://microbotmedical.com
Valuation
|
Metric
|
MBOT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.34 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
MBOT
Financial Strength
|
Metric
|
MBOT
|
|---|---|
Quick Ratio | 2.08 |
Current Ratio | 2.09 |
Interest Coverage | — |
Quick Ratio
MBOT
Profitability
|
Metric
|
MBOT
|
|---|---|
Return on Assets (Normalized) | −97.09% |
Return on Equity (Normalized) | −127.21% |
Return on Invested Capital (Normalized) | −125.27% |
Return on Assets
MBOT
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Vtqyvszy | Csh | $132.6 Bil | |
BDX
| Becton Dickinson & Co | Dgytzyhz | Xtswlz | $67.9 Bil | |
ALC
| Alcon Inc | Tzzgycxj | Yxqpf | $38.9 Bil | |
CLPBY
| Coloplast A/S ADR | Xfflbbkycs | Kwbb | $28.8 Bil | |
WST
| West Pharmaceutical Services Inc | Fndfrctqp | Yrtk | $27.8 Bil | |
RMD
| ResMed Inc | Lrzvqrmtz | Gmwdpf | $25.6 Bil | |
BAX
| Baxter International Inc | Lmkxknm | Ygfqkwz | $20.1 Bil | |
COO
| The Cooper Companies Inc | Qhqrldvpq | Rzxys | $17.9 Bil | |
HOLX
| Hologic Inc | Bxtdcpht | Ksdgj | $17.6 Bil | |
TFX
| Teleflex Inc | Qnlj | Cmlz | $9.8 Bil |